Neuropsychological exploration of alleged mold neurotoxicity

Archives of Clinical Neuropsychology

Volumn 22, Issue 4, 2007, Pages 533-543

  Reinhard, Matthew J ^a   Satz, Paul ^a   Scaglione, Cris A ^b   D'Elia, Louis F ^a   Rassovsky, Yuri ^a   Arita, Anthony A ^a   Hinkin, Charles H ^a   Thrasher, Delaney ^a   Ordog, Gary ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FIELDING GRADUATE UNIVERSITY   (United States)

^c Clinical Forensic Medicine   (United States)

Author keywords

Cognition; Litigation; MMPI; Mold; Neurotoxicity; Stachybotrys

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; EMOTION; EXPOSURE; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; MOULD; NEUROPSYCHOLOGY; NEUROTOXICITY; OUTCOME ASSESSMENT;

EID: 34249683826     PISSN: 08876177     EISSN: 18735843     Source Type: Journal    
DOI: 10.1016/j.acn.2007.03.006     Document Type: Article

References (36)

1. Baldo J.V., Ahmed L., and Ruff R. Neuropsychological performance of patients following mold exposure. Applied Neuropsychology 9 (2002) 193-202
2. Belanger H.G., Curtiss G., Demery J.A., Lebowitz B.K., and Vanderploeg R.D. Factors moderating neuropsychological outcomes following mild traumatic brain injury: A meta-analysis. Journal of the International Neuropsychological Society 11 (2005) 215-227
3. Blair J.R., and Spreen O. Predicting premorbid IQ: A revision of the National Adult reading test. The Clinical Neuropsychologist 3 (1989) 129-136
4. Butcher J.N., Dahlstrom W.G., Graham J.R., Tellegen A., and Kaemmer B. Minnesota multiphasic personality inventoru-2 (MMPI-2): Manual for administration and scoring (1989), University of Minnesota Press, Minneapolis
5. California Department of Health Services (CADHS) (2000). Stachybotrys chartarum: A mold that may be found in water damaged homes. http://www.dhs.ca.gov/ehib/ehib2/topics/stachygp00.doc
6. Castellon S.A., Hardy D.J., Hinkin C.H., Satz P., Stenquist P.K., van Gorp W.G., et al. Components of depressionin HIV-1 infection: Their differential relationship to neurocognitive performance. Journal of Clinical and Experimental Neuropsychology 28 3 (2006) 420-437
7. Castellon S.A., Hinkin C.H., Wood S., and Yarema K.T. Apathy, depression, and cognitive performance in HIV-1 infection. Journal of Neuropsychiatry and Clinical Neurosciences 10 3 (1998) 320-329
8. Centers for Disease Control and Prevention (CDC) (2002). State of the science on molds and human health. Statement of Stephen C. Redd, for the record before the Subcommittees on Oversight and Investigations and Housing and Community Opportunity, Committee on Financial Services, United States House of Representatives.
9. Crago R.B., Gray M.R., Nelson L.A., Davis M., Arnold L., and Thrasher J.D. Psychological, neuropsychological, and electrocortical effects of mixed mold exposure. Archives of Environmental Health 58 8 (2003) 436-452
10. Gordon W.A., Cantor J.B., Johanning E., Charatz H.J., Ashman T.A., Breeze J.L., et al. Cognitive impairment associated with toxigenic fungal exposure: A replication and extension of previous findings. Applied Neuropsychology 11 2 (2004) 65-74
11. Gordon W.A., Johanning E., and Haddad L. Cognitive impairment associated with exposure to toxigenic fungi. In: Johanning E. (Ed). Bioaerosols, fungi and mycotoxins: Health effects, assessment, prevention and control (1999), Eastern New York Occupational and Environmental Health, New York 94-98
12. Gray M.R., Thrasher J.D., Crago R., Madison R.A., Arnold L., Campbell A.W., et al. Mixed mold mycotoxicosis:Immunological changes in humans following exposure in water-damaged buildings. Archives of Environmental Health 58 7 (2003) 410-419
13. Greiffenstein M.F., Baker W.J., Gola T., Donders J., and Miller L. The fake bad scale in atypical and severe closed head injury litigants. Journal of Clinical Psychology 58 (2002) 1591-1600
14. Heaton R.K., Grant I., Butters N., White D.A., Kirson D., Atkinson J.H., et al. the HNRC Group. The HNRC 500-Neuropsychology of HIV infection at differentdisease stages. Journal of the International Neuropsychological Society 1 (1995) 231-251
15. Hinkin C.H., van Gorp W.G., Weisman J.D., Thommes J., and Buckingham S. Depressed mood and its relationship to neuropsychological test performance in HIV-1 seropositive individuals. Journal of Clinical and Experimental Neuropsychology 14 2 (1992) 289-297
16. Hunter C.A., Grant C., Flannigan B., and Bravery A.F. Mold in buildings: The air spora of domestic dwellings. International Biodeterioration 24 (1988) 81-101
17. Institute of Medicine (IOM). Damp indoor spaces and health (2004), National Academies Press, Washington, DC
18. Johanning E., Landsbergis P., Gareis M., Yang C.S., and Olmstead E. Clinical experience and results of a Sentinel Health Investigation related to indoor fungal exposure. Environmental Health Perspectives 107 (1999) 489-494
19. Kuhn D.M., and Ghannoum M.A. Indoor mold, toxigenic fungi, and stachybotrys chartarum: Infectious disease perspective. Clinical Microbiology Reviews 16 1 (2003) 144-172
20. Larrabee G.J. Detection of symptom exaggeration with the MMPI-2 in litigants with malingered neurocognitive dysfunction. The Clinical Psychologist 17 (2003) 54-68
21. Lees-Haley P.R., English L.T., and Glenn W.J. A Fake Bad Scale on the MMPI-2 for personal injury claimants. Psychological Reports 68 1 (1991) 203-210
22. Lees-Haley P.R. Toxic mold mycotoxins in neurotoxicity cases: Stachybotrys, fusarium, trichoderma, aspergillus, penicillium, cladosporium, alternaria, trichotheecenes. Psychological Reports 93 (2003) 561-584
23. Mittenberg W., Patton C., Canyock E.M., and Condit D.C. Base rates of malingering and symptom exaggeration. Journal of Clinical and Experimental Neuropsychology 24 (2002) 1094-1102
24. Morey L.C. Personality assessment inventory: Professional manual (1991), Psychological Assessment Resources, Odessa, FL
25. Nelson N.W., Parsons T.D., Grote C.L., Smith C.A., and Sisung I.I.J.R. The MMPI-2 fake bad scale: Concordance and specificity of true and estimated scores. Journal of Clinical and Experimental Neuropsychology 28 (2006) 1-12
26. Rey A. L'examen clinique en psychologie (1964), Press Universitaires de France, Paris
27. Rippeth J.D., et al. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society 10 (2004) 1-14
28. Satz P., Forney D.L., Zaucha K., Asarnow R.R., Light R., McCleary C., et al. Depression, cognition, and functional correlates of recovery outcome after traumatic brain injury. Brain Injury 12 7 (1998) 537-553
29. Slick D., Hopp G., Strauss E., and Thompson G.B. Victoria symptom validity test (1997), Psychological Assessment Resources, Odessa, FL
30. Spreen O., and Strauss E. A compendium of neuropsychological tests: Administration, norms, and commentary (1998), Oxford University Press, New York
31. Stone D., Boone K.B., Carla B., and Lessler I.M. Somatization and malingering of cognitive deficit in six cases of "oxic mold" exposure. Poster Session Presented at the Annual Meeting of the International Neuropsychological Society. Boston, MA, February (2006)
32. Tsushima W.T., and Tsushima V.G. Comparison of the fake bad scale and other MMPI-2 validity scales with personal injury litigants. Assessment 8 (2001) 205-212
33. Tombaugh T.N. Test of memory malingering (1997), Western Psychological Services, Los Angeles
34. Tuomi T., Reijula K., Johnsson T., Hemminki K., Hintikka E., Lindroos O., et al. Mycotoxins in crude building materials from water damaged buildings. Applied and Environmental Microbiology 66 5 (2000) 1899-1904
35. Warrington E.K. Recognition memory test (1984), Western Psychological Services, Los Angeles
36. Wechsler D. WAIS-III/WMS-III: Technical manual (1997), The Psychological Corporation, San Antonio, TX